Salix Sues Novel Labs Over Bowel Cleanser Patent

Law360, New York (May 15, 2008, 12:00 AM EDT) -- Salix Pharmaceuticals Inc. has hit Novel Laboratories Inc. with a patent suit in a bid to maintain control over the U.S. market for MoviPrep, which is used for bowel cleansing prior to colonoscopies, intestinal surgery and barium enema X-ray exams.

Salix, Norgine BV and Norgine Europe BV filed their complaint on Wednesday in the U.S. District Court for the District of New Jersey. In December 2005, Salix struck a deal with Amsterdam-based Norgine under which Salix was granted the exclusive right to sell MoviPrep in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.